Luminex releases xPONENT 3.1 software
Launched for use on Luminex 100 and Luminex 200 systems, xPONENT 3.1 includes more than 65 new features designed to benefit scientists and laboratory professionals across research and
Amberstone Biosciences has signed a partnership and licence agreement with Shanghai Henlius Biotech for conditionally activated T-cell engager candidates to treat solid tumours.